Related references
Note: Only part of the references are listed.A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine
Peter T. Beernink et al.
MBIO (2019)
Anti-Factor H Antibody Reactivity in Young Adults Vaccinated with a Meningococcal Serogroup B Vaccine Containing Factor H Binding Protein
Kelsey Sharkey et al.
MSPHERE (2019)
Variant Signal Peptides of Vaccine Antigen, FHbp, Impair Processing Affecting Surface Localization and Antibody-Mediated Killing in Most Meningococcal Isolates
Ronni A. G. da Silva et al.
FRONTIERS IN MICROBIOLOGY (2019)
Structural basis for cooperativity of human monoclonal antibodies to meningococcal factor H-binding protein
Ilaria Peschiera et al.
COMMUNICATIONS BIOLOGY (2019)
From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine
John L. Perez et al.
EXPERT REVIEW OF VACCINES (2018)
Crystal structure reveals vaccine elicited bactericidal human antibody targeting a conserved epitope on meningococcal fHbp
Jacinto Lopez-Sagaseta et al.
NATURE COMMUNICATIONS (2018)
Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopes
M. Giuliani et al.
SCIENTIFIC REPORTS (2018)
Meningococcal serogroup B vaccines: Estimating breadth of coverage
Robert G. K. Donald et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Emergence of a new Neisseria meningitidis clonal complex 11 lineage 11.2 clade as an effective urogenital pathogen
Yih-Ling Tzeng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Impaired Immunogenicity of Meningococcal Neisserial Surface Protein A in Human Complement Factor H Transgenic Mice
Eduardo Lujan et al.
INFECTION AND IMMUNITY (2016)
Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined
Massimiliano Biagini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Evolutionary Events Associated with an Outbreak of Meningococcal Disease in Men Who Have Sex with Men
Muhamed-Kheir Taha et al.
PLOS ONE (2016)
Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding
Dan M. Granoff et al.
JCI INSIGHT (2016)
Neisseria meningitidis: pathogenesis and immunity
Mariagrazia Pizza et al.
CURRENT OPINION IN MICROBIOLOGY (2015)
Binding of Complement Factor H (FH) Decreases Protective Anti-FH Binding Protein Antibody Responses of Infant Rhesus Macaques Immunized With a Meningococcal Serogroup B Vaccine
Dan M. Granoff et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
A Newly-Identified Polymorphism in Rhesus Macaque Complement Factor H Modulates Binding Affinity for Meningococcal FHbp
Monica Konar et al.
PLOS ONE (2015)
Effect of complement Factor H on anti-FHbp serum bactericidal antibody responses of infant rhesus macaques boosted with a licensed meningococcal serogroup B vaccine
Serena Giuntini et al.
VACCINE (2015)
Complementing the sugar coce: role of GAGs and sialic acid in complement regulation
Alex Langford-Smith et al.
FRONTIERS IN IMMUNOLOGY (2015)
Structural basis for sialic acid-mediated self-recognition by complement factor H
Baerbel S. Blaum et al.
NATURE CHEMICAL BIOLOGY (2015)
Heterogeneity in Rhesus Macaque Complement Factor H Binding to Meningococcal Factor H Binding Protein (FHbp) Informs Selection of Primates To Assess Immunogenicity of FHbp-Based Vaccines
Peter T. Beernink et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Nonfunctional Variant 3 Factor H Binding Proteins as Meningococcal Vaccine Candidates
Stijn van der Veen et al.
INFECTION AND IMMUNITY (2014)
Human Factor H (FH) Impairs Protective Meningococcal Anti-FHbp Antibody Responses and the Antibodies Enhance FH Binding
Isabella Costa et al.
MBIO (2014)
Does Binding of Complement Factor H to the Meningococcal Vaccine Antigen, Factor H Binding Protein, Decrease Protective Serum Antibody Responses?
Dan M. Granoff et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
Genetic Distribution of Noncapsular Meningococcal Group B Vaccine Antigens in Neisseria lactamica
Jay Lucidarme et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment
Ulrich Vogel et al.
LANCET INFECTIOUS DISEASES (2013)
Temperature triggers immune evasion by Neisseria meningitidis
Edmund Loh et al.
NATURE (2013)
Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen
Enrico Malito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice
Raffaella Rossi et al.
VACCINE (2013)
Conservation of Meningococcal Antigens in the Genus Neisseria
Alessandro Muzzi et al.
MBIO (2013)
Factor H-Dependent Alternative Pathway Inhibition Mediated by Porin B Contributes to Virulence of Neisseria meningitidis
Lisa A. Lewis et al.
MBIO (2013)
The Factor H Binding Protein of Neisseria meningitidis Interacts with Xenosiderophores in Vitro
Daniele Veggi et al.
BIOCHEMISTRY (2012)
Complement Factor H-ligand interactions: Self-association, multivalency and dissociation constants
Stephen J. Perkins et al.
IMMUNOBIOLOGY (2012)
Enhanced Bacteremia in Human Factor H Transgenic Rats Infected by Neisseria meningitidis
David M. Vu et al.
INFECTION AND IMMUNITY (2012)
Design of Meningococcal Factor H Binding Protein Mutant Vaccines That Do Not Bind Human Complement Factor H
Rolando Pajon et al.
INFECTION AND IMMUNITY (2012)
The Relative Roles of Factor H Binding Protein, Neisserial Surface Protein A, and Lipooligosaccharide Sialylation in Regulation of the Alternative Pathway of Complement on Meningococci
Lisa A. Lewis et al.
JOURNAL OF IMMUNOLOGY (2012)
The effect of iron availability on transcription of the Neisseria meningitidis fHbp gene varies among clonal complexes
Holly Sanders et al.
MICROBIOLOGY-SGM (2012)
Transcriptional Profiling of Serogroup B Neisseria meningitidis Growing in Human Blood: An Approach to Vaccine Antigen Discovery
Asa K. Hedman et al.
PLOS ONE (2012)
The Effect of Human Factor H on Immunogenicity of Meningococcal Native Outer Membrane Vesicle Vaccines with Over-Expressed Factor H Binding Protein
Peter T. Beernink et al.
PLOS PATHOGENS (2012)
Design and Evaluation of Meningococcal Vaccines through Structure-Based Modification of Host and Pathogen Molecules
Steven Johnson et al.
PLOS PATHOGENS (2012)
Characterization of Neisseria meningitidis Isolates That Do Not Express the Virulence Factor and Vaccine Antigen Factor H Binding Protein
Jay Lucidarme et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Complement-Mediated Bactericidal Activity of Anti-Factor H Binding Protein Monoclonal Antibodies against the Meningococcus Relies upon Blocking Factor H Binding
Serena Giuntini et al.
INFECTION AND IMMUNITY (2011)
A Meningococcal Factor H Binding Protein Mutant That Eliminates Factor H Binding Enhances Protective Antibody Responses to Vaccination
Peter T. Beernink et al.
JOURNAL OF IMMUNOLOGY (2011)
Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1
Brunella Brunelli et al.
VACCINE (2011)
Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and Neisserial heparin binding antigen
David M. Vu et al.
VACCINE (2011)
Transcriptome Analysis of Neisseria meningitidis in Human Whole Blood and Mutagenesis Studies Identify Virulence Factors Involved in Blood Survival
Hebert Echenique-Rivera et al.
PLOS PATHOGENS (2011)
Expression of Factor H Binding Protein of Meningococcus Responds to Oxygen Limitation through a Dedicated FNR-Regulated Promoter
Francesca Oriente et al.
JOURNAL OF BACTERIOLOGY (2010)
Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans
Davide Serruto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection
Kate L. Seib et al.
VACCINE (2010)
Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease
Han-Qing Jiang et al.
VACCINE (2010)
The Meningococcal Vaccine Candidate Neisserial Surface Protein A (NspA) Binds to Factor H and Enhances Meningococcal Resistance to Complement
Lisa A. Lewis et al.
PLOS PATHOGENS (2010)
Binding of Complement Factor H (fH) to Neisseria meningitidis Is Specific for Human fH and Inhibits Complement Activation by Rat and Rabbit Sera
Dan M. Granoff et al.
INFECTION AND IMMUNITY (2009)
Functional Comparison of the Binding of Factor H Short Consensus Repeat 6 (SCR 6) to Factor H Binding Protein from Neisseria meningitidis and the Binding of Factor H SCR 18 to 20 to Neisseria gonorrhoeae Porin
Jutamas Shaughnessy et al.
INFECTION AND IMMUNITY (2009)
Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086
Alessandro Mascioni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Solution Structure of the Factor H-binding Protein, a Survival Factor and Protective Antigen of Neisseria meningitidis
Francesca Cantini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Sequence Diversity of the Factor H Binding Protein Vaccine Candidate in Epidemiologically Relevant Strains of Serogroup B Neisseria meningitidis
Ellen Murphy et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Epitope Mapping of a Bactericidal Monoclonal Antibody against the Factor H Binding Protein of Neisseria meningitidis
Maria Scarselli et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates
Muriel C. Schneider et al.
NATURE (2009)
The modular architecture of meningococcal factor H-binding protein
Peter T. Beernink et al.
MICROBIOLOGY-SGM (2009)
Variation of the factor H-binding protein of Neisseria meningitidis
Carina Brehony et al.
MICROBIOLOGY-SGM (2009)
Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus
Stefania Bambini et al.
VACCINE (2009)
Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor H-binding protein
Peter T. Beernink et al.
INFECTION AND IMMUNITY (2008)
Molecular characterization of nitrite reductase gene (aniA) and gene product in Neisseria meningitidis isolates: Is aniA essential for meningococcal survival?
Paola Stefanelli et al.
IUBMB LIFE (2008)
Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen
Jo Anne Welsch et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Structural basis for complement factor H-linked age-related macular degeneration
Beverly E. Prosser et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
A universal vaccine for serogroup B meningococcus
Marzia M. Giuliani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Rapid genetic grouping of factor H-binding protein (genome-derived neisserial antigen 1870), a promising group B meningococcal vaccine candidate
Peter T. Beernink et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance
Guillermo Madico et al.
JOURNAL OF IMMUNOLOGY (2006)
Functional significance of factor H binding to Neisseria meningitidis
Muriel C. Schneider et al.
JOURNAL OF IMMUNOLOGY (2006)
Role of FNR and FNR-regulated, sugar fermentation genes in Neisseria meningitidis infection
E Bartolini et al.
MOLECULAR MICROBIOLOGY (2006)
Complement escape of human pathogenic bacteria by acquisition of complement regulators
P Kraiczy et al.
MOLECULAR IMMUNOLOGY (2006)
The pathogen Neisseria meningitidis requires oxygen, but supplements growth by denitrification.: Nitrite, nitric oxide and oxygen control respiratory flux at genetic and metabolic levels
JD Rock et al.
MOLECULAR MICROBIOLOGY (2005)
MeNZB™:: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain
P Oster et al.
VACCINE (2005)
The region comprising amino acids 100 to 255 of Neisseria meningitidis, lipoprotein GNA 1870 elicits bactericidal antibodies
MM Giuliani et al.
INFECTION AND IMMUNITY (2005)
Vaccine potential of the Neisseria meningitidis 2086 lipoprotein
LD Fletcher et al.
INFECTION AND IMMUNITY (2004)
Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine
JA Welsch et al.
JOURNAL OF IMMUNOLOGY (2004)
Crystal structure of Neisserial surface protein A (NspA), a conserved outer membrane protein with vaccine potential
L Vandeputte-Rutten et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870
V Masignani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing
M Pizza et al.
SCIENCE (2000)
Complete genome sequence of Neisseria meningitidis serogroup B strain MC58
H Tettelin et al.
SCIENCE (2000)
Share Paper
